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Abstract
Persistent cellular migration requires efficient protrusion of the front of the cell, the leading edge where the actin
cytoskeleton and cell-substrate adhesions undergo constant rearrangement. Rho family GTPases are essential regulators of
the actin cytoskeleton and cell adhesion dynamics. Here, we examined the role of the RhoGEF TEM4, an activator of Rho
family GTPases, in regulating cellular migration of endothelial cells. We found that TEM4 promotes the persistence of cellular
migration by regulating the architecture of actin stress fibers and cell-substrate adhesions in protruding membranes.
Furthermore, we determined that TEM4 regulates cellular migration by signaling to RhoC as suppression of RhoC expression
recapitulated the loss-of-TEM4 phenotypes, and RhoC activation was impaired in TEM4-depleted cells. Finally, we showed
that TEM4 and RhoC antagonize myosin II-dependent cellular contractility and the suppression of myosin II activity rescued
the persistence of cellular migration of TEM4-depleted cells. Our data implicate TEM4 as an essential regulator of the actin
cytoskeleton that ensures proper membrane protrusion at the leading edge of migrating cells and efficient cellular
migration via suppression of actomyosin contractility.
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Introduction
Cellular migration plays a critical role in many physiological
and pathological processes including normal cell embryogenesis,
wound healing, and tumor cell metastasis. Migrating cells
advance by extending their front and retracting their rear [1].
Protrusion of the cell front (leading edge) is regulated by
continuous remodeling of the actin cytoskeleton and formation
of F-actin filaments crosslinked with myosin II [2,3,4,5]. The
assembly of actin filaments into an actomyosin-crosslinked
contractile network is essential for membrane protrusion and
whole cell migration [2,5,6]. However, myosin II-driven
contractility at the cell front is tightly regulated during cell
migration to ensure leading edge advance, as inhibition of
myosin II activity promotes leading edge protrusion [5,7,8,9].
Rho family GTPases are key regulators of actin cytoskeleton
dynamics [1,10]. Biochemically, Rho GTPases are molecular
switches that cycle dynamically between inactive, GDP-bound
and active, GTP-bound states [11]. Guanine nucleotide
exchange factors for Rho GTPases (RhoGEFs) catalyze the
exchange of bound GDP for GTP to favor formation of Rho-
GTP and activation of downstream effector functions [12,13].
The largest family of RhoGEFs in humans is the Dbl family of
proteins [12]. Dbl family proteins are characterized by a
tandem catalytic Dbl homology (DH) and regulatory pleckstrin
homology (PH) domain cassette responsible for accelerating the
intrinsic nucleotide exchange activity of Rho GTPases.
TEM4 (tumor endothelial marker 4) was identified originally
as a gene whose expression was upregulated in endothelial cells
during tumor cell-induced angiogenesis [14]. Recently, we have
shown that TEM4 is a Rho-specific guanine nucleotide
exchange factor (GEF) and a member of Dbl family of
RhoGEFs [12,15]. However, the role of TEM4 in endothelial
cell biology remains to be determined.
Here, we show that TEM4 regulates endothelial cell
migration. Specifically, TEM4 signaling is essential to maintain
the organization of the actin cytoskeleton and focal adhesions in
protrusive areas of the cell. We show that TEM4 mediates its
function, at least in part, by suppressing actomyosin contractil-
ity. Our data implicate TEM4 as an essential regulator of the
actin cytoskeleton to ensure proper membrane protrusion of the
leading edge and efficient endothelial cell migration.
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Results
TEM4 is a Regulator of Angiogenesis
The identification of TEM4 in a screen for regulators of
angiogenesis in vivo [14], where TEM4 expression was found to be
upregulated in tumor vasculature of colorectal cancer patients,
suggested that this RhoGEF may serve an important role during
angiogenesis. To determine whether TEM4 is involved in
angiogenesis, we utilized a mouse embryonic stem (ES) cell
differentiation model of vascular development. Mouse ES cells,
derived from the inner cell mass of blastocyst stage embryos,
undergo programmed differentiation in vitro to form a primitive
vasculature that closely resembles early vascular development
in vivo [16,17,18,19,20]. In this assay, aggregated ES cells are
partially differentiated in suspension to form embryoid bodies
(EBs) (Fig. 1A, day 1–3) which are then replated for attachment
(day 3). During the next several days, EBs differentiate into
multiple cell types, including endothelial cells that proliferate and
migrate to form primitive vessels, giving rise to a highly branched
vascular network [19,21,22]. Using RT-PCR analysis, we found
that Tem4 expression increased during development of ES cell–
derived vessels (Fig. 1B; Days 5–7). As expected, expression of
VEGFR-1 appeared at day 4 and persisted throughout ES cell
differentiation [23]. These data indicate that Tem4 is upregulated
during vascular development in the ES model of angiogenesis,
which is consistent with TEM4 expression during angiogenesis
in vivo [14]. Knockdown of Tem4 during ES cell differentiation did
not impair ES cell growth or formation of EBs (Fig. 1C). However,
the loss of Tem4 severely impaired blood vessel formation,
decreasing total vessel surface area and branching (Fig. 1, E and
F). These results suggest that TEM4 is essential for angiogenesis.
To further examine a possible role of TEM4 in angiogenesis, we
performed Matrigel tubulogenesis assay on human umbilical vein
primary endothelial cells (HUVECs). When plated on Matrigel,
endothelial cells spread on the Matrigel, migrate towards each
other and fuse to form pre-capillary cords closely resembling the
in vivo vasculature [24,25,26]. Monitoring cells undergoing tubu-
logenesis on the Matrigel would allow us to identify distinct steps at
which TEM4 may impact in vivo angiogenesis. As shown in
Figure 1G, within 3–6 h of plating control cells migrated towards
each other and began aligning to form vascular webs. On the
contrary, TEM4-depleted cells lagged behind and failed to form
complex webs seen in control cells even by 24 h (Fig. 1H). Defects
in tubulogenesis of TEM4-depleted cells suggest that TEM4 may
regulate the most fundamental cellular processes such as cellular
adhesion and migration.
TEM4 and RhoC Regulate Persistence of Endothelial Cell
Migration
To determine if TEM4 regulates endothelial cell migration, we
monitored cellular motility of HUVECs depleted of TEM4 by
shRNA. From these analyses, we observed that cells depleted of
TEM4 made frequent 90u turns and consequently, they ineffi-
ciently migrated away from the point of origin when compared to
control cells expressing non-specific (NS) shRNA (Fig. 2A, Movie
S1–S2). As we previously identified RhoC as an in vivo target of
TEM4, we determined if RhoC has a function in endothelial cell
migration. Cells depleted of RhoC exhibited a similar loss of
directionality of migration phenotype as was seen with TEM4
depletion (Fig. 2A, Movie S3). Consistent with our visual
observations, we found that persistence of migration (calculated
as net displacement from origin/total length of migration path)
was significantly decreased in cells with decreased TEM4 or RhoC
expression levels (Fig. 2B–C, Fig. S1), suggesting that TEM4
regulates persistence of endothelial cell migration in part through
RhoC activation.
TEM4 Activates RhoC in Protruding Membranes
We next determined if TEM4-dependent migration was
associated with RhoC activation. A previous study suggested that
RhoC is activated in membrane protrusions at the leading edge
[27]. We therefore determined if activation of RhoC in membrane
protrusions of endothelial cells is impaired in cells depleted of
TEM4. To visualize activation of RhoC in membrane protrusions,
we utilized a bimolecular fluorescence complementation (BiFC)
assay, a widely accepted approach for studying spatial localization
of protein-protein interactions [28,29] and, more recently, utilized
to study activation of the Ras GTPase protein [30]. Using
available structural data [31,32], we designed a BiFC probe for
RhoC activation by fusing wild-type full-length RhoC to the N-
terminus of Venus (VN; residues 1–154), a spectral derivative of
the GFP protein [33], and the Rho-binding domain (RBD) of
ROCKI (residues 947–1015) to a Venus C-terminal fragment
(VC; residues 155–238) (Fig. 3 A and Fig. S2A). Functional
fluorescent Venus protein is then reconstituted from the separate
N- and C-terminal fragments [34] upon the specific binding of
activated GTP-bound RhoC to the RBD (Fig. 3 A). Because wild-
type RhoC protein is used in Venus fusion, it must be GTP-loaded
by a RhoGEF to promote RBD binding. Therefore, the RhoC-
BiFC probe can be used to monitor activation of RhoC in vivo. We
have validated the specificity of RhoC-BiFC probe (see Results S1
and Figs. S2–S3) and concluded that the BiFC-based sensor can be
used to visualize the spatial activation of RhoC in cells.
To determine if TEM4 promotes activation of RhoC in
membrane protrusions, we visualized activation of RhoC in
control NS and TEM4-depleted cells using spinning disk confocal
microscopy. The F-actin marker, Lifeact [35] was used along with
BiFC sensor to ensure that all movies were collected in the same
focal plane towards the bottom of each cell. As we speculated, an
increase in BiFC signal indicating activation of RhoC was detected
in protruding membranes in NS control cells (Fig. 3B, D, F and
Movie S4). More importantly, TEM4 knockdown severely
impaired RhoC activation in protruding membranes (Fig. 3B, E,
F and Movie S5) indicating TEM4-dependent RhoC activation.
Although the role of RhoC in endothelial cell migration has not
been established, in general, Rho GTPases are activated in
membrane protrusions to promote persistent migration in part by
regulating protrusion of the leading edge [36,37]. Taken together,
our data suggest that TEM4 promotes activation of RhoC in
endothelial cells and is likely to signal through RhoC to promote
persistent cellular migration.
TEM4 and RhoC Regulate Actin Network Organization in
Protruding Membranes
Proper organization of the actin cytoskeleton at the leading edge
of migrating cells is essential for membrane protrusion and
persistent cell movement [2,5,6]. Given the essential role of Rho
GTPases in regulating the polymerization and reorganization of
the actin cytoskeleton, we hypothesized that TEM4 and RhoC
regulate membrane protrusion and, therefore, cell migration by
regulating the actin cytoskeleton in protruding membranes. To test
our hypothesis, we examined the F-actin cytoskeleton in cells
depleted of RhoC by time-lapse imaging of cells expressing F-actin
marker, Lifeact. First, we observed membrane protrusions in
whole cells. Time-lapse imaging of NS control cells expressing
GFP-Lifeact revealed directional protrusion of the leading edge
(Fig. 4 A top row, green arrowheads and Movie S6). In contrast,
membrane protrusions in RhoC-depleted cells were prone to
RhoGEF TEM4 Controls Endothelial Cell Migration
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multiple rounds of retraction (Fig. 4 A bottom row, red
arrowheads), each followed by membrane protrusions of the
collapsed areas (Fig. 4 A bottom row, green arrowheads and
Movie S7). Kymography analysis of RhoC- depleted cells revealed
that protrusions of the leading edge had a much shorter
persistence and altered protrusion/retraction rates of the leading
edge as compared to NS control cells. This leading edge behavior
led to frequent turning events observed in whole cell migration
analyses (Fig. 2).
Figure 1. TEM regulates blood vessel formation. (A) Cartoon describing differentiation of ES cells to form blood vessels. EBs, embryoid bodies.
(B) RT-PCR analysis of Tem4, VEGFR-1 and Gapdh expression during differentiation of ES cells. ES, embryonic stem cells prior to dispersion by dispase
treatment. Data are representative of two independent experiments. (C) Knockdown of TEM4 does not inhibit differentiation of ES cells into EBs. (D)
Western blot confirming knockdown of TEM4 in ES cells by lentivirus-based RNAi construct. (E, F) Loss of TEM4 impairs blood vessel formation.
Differentiated ES cell cultures were fixed on day 8 and vessels visualized by staining with PECAM (E). PECAM-positive surface area was measured and
graphed (F) as described in Materials and methods. Scale bar, 200 mm. (G) Loss of TEM4 impairs Matrigel tubule formation in vitro. Phase contrast
images of HUVECs expressing NS control or TEM4 shRNA undergoing in vitro tubulogenesis on Matrigel surface. (H) Quantitation of Matrigel tubule
formation assay (n = 3, 4 fields/well).
doi:10.1371/journal.pone.0066260.g001
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Second, we inspected the actin cytoskeleton in protruding
membranes of the leading edge. As shown in Figure 4 C, F-actin
filaments appeared dramatically different between control and
RhoC-depleted cells. In NS control cells, individual well-spaced
actin filaments that ran parallel to the protruding edge were easily
identifiable (Fig. 4 C top row). In contrast, in RhoC-depleted cells,
actin stress fibers remained parallel to the protruding edge but
were present in thick bundles (Fig. 4 C bottom row and data not
shown). These bundles formed during strong retractions of the
leading edge as the existing individual actin filaments collapsed
onto one another (Fig. 4 C bottom row, asterisk). These thick actin
stress fibers persisted even as the membrane began to protrude
again (Fig. 4 A bottom row, 76 and 89 min time frame) and were
observed in a large majority (80–100%) of TEM4- or RhoC-
depleted cells (Figure 5 A–B). Our data suggested that TEM4 and
RhoC were essential for the regulation of actin cytoskeleton in
protruding membranes. The abnormal actin stress fibers in
TEM4- or RhoC-depleted cells could be an underlying cause for
the membrane protrusion defects and would account for the loss of
persistence in whole cell migration assay.
TEM4 and RhoC Suppress Myosin Contractility
Actomyosin contractility is an essential regulator of actin
cytoskeleton and promotes maintenance of actin filaments in
protruding membranes [5,6]. Given its critical role in maintaining
the actin cytoskeleton, actomyosin contractility needs to be tightly
controlled during membrane protrusion/retraction phases to allow
for efficient cell migration. Therefore, we suspected that excessive
actomyosin contractility in cells depleted of TEM4 or RhoC may
be an underlying cause of protrusive area collapse and the
appearance of abnormal actin filaments. To determine if
actomyosin activity was elevated in cells depleted of TEM4 or
RhoC, we measured the phosphorylation of the regulatory myosin
light chain (MLC2), which is an indicator of myosin II activity. We
did not observe a significant overall difference in the levels of
phospho-MLC2 in cells maintained under steady-state conditions
in growth media (Fig. 6, GM). Therefore, we acutely stimulated
myosin contractility by treatment with nocodazole and allowed
contractility to return to a basal level during nocodazole washout
[38,39,40]. Nocodazole treatment caused a significant increase in
the level of phospho-MLC2 (Fig. 6) that was not altered by the
depletion of TEM4 or RhoC (Fig. 6). However, when compared to
control NS cells, where a rapid decline of phospho-MLC2 levels
following the nocodazole washout was seen, depletion of TEM4 or
RhoC prevented this decline, leading to persistence in phospho-
MLC2 levels (Fig. 6; 10 min GM). Therefore, we concluded that
TEM4 and RhoC act to restrict myosin II activity to allow
protrusion of the leading edge and persistent cellular migration.
The finding that TEM4 suppresses contractility was somewhat
surprising as TEM4 possesses catalytic activity towards RhoA [15],
a well-known activator of actomyosin contractility [41,42,43].
Therefore, we measured activation of RhoA in cells depleted of
TEM4 or RhoC under nocodazole washout conditions used to
measure contractility changes. As shown in Figure S4, RhoA was
hyperactivated in cells depleted of TEM4 or RhoC suggesting that
TEM4 and RhoC antagonize contractility by antagonizing the
activation of RhoA. It should be noted that the observed increase
in RhoA total protein levels in RhoC-depleted cells is consistent
Figure 2. TEM4 regulates persistence of endothelial cell migration. (A) Wind-Rose plots depicting migratory tracks of six individual migrating
cells in each experimental group. Values on x and y scales are arbitrary. (B) Persistence of two-dimensional cellular migration of HUVECs expressing
NS, TEM4, or RhoC shRNAs. Data shown are the mean 6 s.e.m. measured from 18–27 individual cells in 3–5 independent experiments. Cells
expressing plasmid-based shRNA constructs were identified by monitoring GFP or mCherry fluorescence (Fig. S1). (C) Western blot confirming
knockdown of TEM4 and RhoC expression levels by lentivirus-based RNAi constructs. NS; non-specific shRNA.
doi:10.1371/journal.pone.0066260.g002
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with a previous study [44] and a result of stabilization of RhoA
protein by a RhoGDI. Although the mechanism of selective
engagement of RhoC over RhoA by TEM4 remains to be
discovered, the ability of cells to antagonize RhoA activation at the
leading edge is essential for membrane protrusion and cellular
migration [45,46,47,48,49].
TEM4 and RhoC Control Focal Adhesions
We next determined if TEM4 and RhoC regulate cell-
substrate adhesion. Actin stress fibers in protruding membranes
are coupled to focal adhesions (FAs) linking a cell to substrate to
provide a traction network for leading edge advance and whole
cell body translocation. Therefore, an increase in contractility
(Fig. 6), as well as an increase in F-actin stress fibers (Fig. 5) in
TEM4- and RhoC-depleted cells would promote a stronger cell-
substrate attachment through FAs and thus impair effective
membrane protrusion. To determine if TEM4 and RhoC
regulate FAs, we depleted TEM4 or RhoC and calculated the
number of FAs per cell by immunofluorescent detection of
endogenous paxillin [50,51,52]. As expected, control cells
displayed small (less than 0.4 mm [53,54]) paxillin-positive
structures indicative of focal complexes at the cell edge, and
FAs that flanked each actin filament in protruding membranes
(Fig. 7 A, B). However, although TEM4 or RhoC knockdown
cells were still able to assemble focal complexes, there was a
dramatic increase (, 40%) in the total number of FAs and a
number of large FAs (Fig. 7 A–C). Therefore, we suggest that
depletion of TEM4 or RhoC causes an increase in cell-substrate
attachment which would be detrimental to efficient cellular
migration.
Suppression of ROCK Activity Rescues Persistent
Migration of TEM4-depleted Cells
Our data suggest that TEM4 regulates the actin cytoskeleton
and modulates cell-substrate adhesion to promote persistent
cellular migration. In addition, TEM4 may function to suppress
Figure 3. TEM4 activates RhoC in migrating cells. (A) Schematic diagram representing the principle of the BiFC assay. N- and C-terminal
fragments of Venus fluorescent protein were fused to wild type RhoC and ROCKI RBD, respectively. An interaction between active, GTP-loaded RhoC
and ROCK would facilitate association between N and C termini of Venus to produce a bimolecular fluorescent complex. (B–D) Activation of RhoC
seen by BiFC assay in HUVECs expressing NS control (B, D) or TEM4 shRNA (C, E) and Lifeact-tRFP fusion protein to visualize actin. The close-up of the
protrusive region demonstrates activation of RhoC in NS control (D) or TEM4-depleted cells (E). (F) Relative fluorescence intensity of areas at the
leading edge as compared to areas within cell body in NS and TEM4-depleted cells. Measurements were performed as described in Methods for 4–5
protrusions throughout the time-lapse in 5 cells each. Scale bar, 10 mm.
doi:10.1371/journal.pone.0066260.g003
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actomyosin contractility as cells with decreased levels of TEM4
expression had higher levels of active myosin. However, it is not
clear if the ability of TEM4 to suppress myosin contractility is
essential for its role in cellular migration. To assess if suppression
of myosin contractility is essential for the role of TEM4 in cellular
migration, we determined if suppression of Rho-associated kinase
(ROCK) activity, a well-established upstream regulator of myosin
contractility [41,42], would rescue the persistence of cellular
migration of TEM4-depleted cells. Consistent with this possibility,
treatment with the ROCK-selective Y-27632 pharmacologic
inhibitor [55] reversed the accumulation of abnormal actin stress
fibers and FA enlargement observed in TEM4-depleted cells (Fig. 8
A, B) and, more importantly, restored persistence of cellular
migration of HUVECs depleted of TEM4 (Fig. 8 C–E and Movie
S8). Treatment with Y-27632 alone did not impair persistence of
cellular migration (Movie S9). Therefore, we conclude that
TEM4-mediated suppression of myosin contractility is critical for
the regulation of the actin cytoskeleton, cell-substrate adhesion and
cellular migration.
Discussion
In this study, we determined whether TEM4, a RhoGEF
implicated in cancer-associated angiogenesis, regulates cellular
migration. We demonstrated that TEM4 regulates persistence of
endothelial cell migration and regulates the actin cytoskeleton
network and focal adhesions in membrane protrusions at the
leading edge of migrating cells. We also found that TEM4
functions to suppress actomyosin contractility and that an ability to
regulate actomyosin contractility is essential for TEM4 function in
cellular migration.
We found that the RhoGEF TEM4 controls the persistence of
migration of endothelial cells and TEM4-RhoC signaling func-
tions to restrict myosin contractility in migrating cells. Further-
more, suppression of myosin contractility is essential for TEM4
function in migrating cells, as treatment of cells with ROCK
inhibitor, an upstream regulator of myosin II, reverses TEM4-
mediated phenotypes. Even though the mechanism by which
TEM4-RhoC suppress myosin II activity remains to be identified,
localized inhibition of contractile forces at the leading edge of cells
was previously shown to be essential for cell migration [47,49] and
Figure 4. RhoC is required to maintain protrusion dynamics of the leading edge. (A) Frames of a time-lapse movie recording GFP-Lifeact to
demonstrate organization of the actin filaments during migration of NS control (top row) or RhoC-depleted cells (bottom row). Green arrows indicate
leading edge protrusion, with red arrows indicating edge retraction. Scale bar, 10 mm. (B) Kymography analysis of membrane protrusions of NS or
RhoC-depleted cells. Sample kymographs and protrusion parameters of HUVECs depleted of RhoC or NS control. In each experimental group, 5–6
protrusions per cell in each of 4–6 cells were analyzed and data are mean 6 s.e.m. (C) Time lapse montage of an area outlined in panel A showing a
close up of actin filaments in protruding membranes of NS control (top row) or RhoC-depleted cells (bottom row). Asterisk marks an individual F-actin
filament to highlight differential appearance between actin filaments in NS and RhoC-depleted cells.
doi:10.1371/journal.pone.0066260.g004
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Figure 5. TEM4 and RhoC are required to maintain proper actin cytoskeleton architecture in lamella. (A) Actin filaments were visualized
by staining with phalloidin and a-actinin 1 in NS control or cells depleted of TEM4 and RhoC. Cells were prepermeabilized with Triton X-100 to
remove cytosolic a-actinin 1. The whole cell and an isolated area of the leading edge are shown. Scale bar, 10 mm. (B) Depletion of TEM4 or RhoC
increases the number of cells with tight actin/a-actinin bundles. Data are mean6 s.e.m. obtained from 42–57 cells in three independent experiments.
doi:10.1371/journal.pone.0066260.g005
Figure 6. TEM4 and RhoC are required to suppress myosin contractility. Knockdown of TEM4 or RhoC impairs cellular ability to down
regulate myosin contractility. Cells depleted of TEM4 or RhoC or NS control were left untreated (GM), treated with nocodazole (Noc) or treated with
nocodazole with subsequent nocodazole washout. Phosphorylation of MLC2 was determined by western blot analysis of whole cell lysates (A),
quantitated using densitometry and graphed (B). Phospho-MLC2 levels in each group were normalized to levels in the untreated NS control cells that
were set to 1. Data are mean 6 s.e.m. measured in three independent experiments.
doi:10.1371/journal.pone.0066260.g006
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for endothelial cell sprouting during angiogenesis [56,57]. It has
also been suggested that tumors utilize a contractility-independent
mode of migration [58,59] and it is possible that this occurs via a
TEM4-RhoC signaling pathway. Future studies will focus on an
investigation of the molecular mechanisms that drive TEM4- and
RhoC-dependent endothelial and tumor cell migration and
invasion to regulate tumor progression.
Depletion of either TEM4 or RhoC inhibits persistence of
cellular migration, and alters actin cytoskeleton and FA morphol-
ogy, suggesting that RhoC activation by TEM4 may mediate
TEM4 functions. Consistent with this, we found that RhoC
Figure 7. Depletion of TEM4 and RhoC causes accumulation of enlarged focal adhesions. (A) Focal adhesions in NS control, TEM4- and
RhoC-depleted HUVECs were visualized by staining with paxillin and phalloidin. The whole cell and an isolated area of the leading edge are shown.
Scale bar, 10 mm. (B, C) Depletion of TEM4 or RhoC leads to an increase in a total number of FAs (B) and number of large FAs (C). Data are mean 6
s.e.m. measured in 10 cells in two independent experiments.
doi:10.1371/journal.pone.0066260.g007
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activation in protruding membranes was severely impaired upon
TEM4 depletion. Interestingly, endogenous TEM4 associates with
both microtubular and actin cytoskeletons in protruding mem-
branes (Fig. S5) suggesting that association with either or both
structures may regulate spatial activation of RhoC by TEM4 as
shown for other RhoGEF family [60,61]. We have previously
shown that TEM4 contains an actin-binding domain which is
required for its ability to activate RhoC in vivo [15], whereas the
mechanism of association of TEM4 with microtubules is unknown.
Further studies are required to determine if the association of
TEM4 with cytoskeletal components dictates spatial activation of
Figure 8. Suppression of ROCK activity in TEM4-depleted cells rescues persistence of cellular migration. (A) Inhibition of ROCK activity
with Y-27632 normalized the appearance of actin cytoskeleton in TEM4-depleted cells. HUVECs were stained with phalloidin and antibody against a-
actinin. (B) Enlarged FAs in TEM4-depleted cells disappear upon treatment with Y-27632. HUVECs were stained with paxillin antibody and phalloidin.
Scale bar, 10 mm. (C) Persistence of 2D cellular migration of HUVECs expressing TEM4 shRNA is restored upon treatment with Y-27632. Data are mean
6 s.e.m. measured from 17 (NS), 26 (TEM4 sh +/2 Y-27632) and 14 (NS+Y-27632) individual cells in three independent experiments. (D, E) Wind-Rose
plots depicting migratory tracks of six individual migrating cells in each experimental group. Values on x and y scales are arbitrary. Scale bar, 10 mm.
doi:10.1371/journal.pone.0066260.g008
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RhoC and if this association is essential for TEM4 function in cell
migration.
Our findings that TEM4-RhoC suppresses phosphorylation of
MLC2 are unexpected. In general, Rho family proteins are
thought to activate MLC2 by signaling through Rho-associated
kinase (ROCK) [62,63]. However, several studies suggested that
RhoC functions independently of ROCK signaling [64,65] and a
recent study reported that RhoC suppresses MLC2 phosphoryla-
tion in response to LPA in osteosarcoma and ovarian cancer cells
[66]. Given the essential role of RhoC in tumorigenesis
[67,68,69,70,71], future studies are required to determine the
mechanism by which RhoC mediates suppression of myosin II
activity and, possibly, tumorigenesis.
The ability of TEM4 and RhoC to regulate leading edge
protrusion undoubtedly stems from the regulation of actin stress
fibers, formation and maintenance of which are essential for
membrane protrusion [5,6]. Loss of TEM4 or RhoC promoted the
accumulation of thick actin bundles in protruding areas of the cell
suggesting that TEM4-RhoC signaling regulates actin stress fiber
formation and distribution. The mechanisms by which TEM4-
RhoC regulate the actin cytoskeleton may involve fine tuning
actomyosin contractility which is required for stress fiber
formation and maintenance [4,5]. In addition, failure to
disassemble FAs may also promote the accumulation of actin
stress fibers at the leading edge observed in TEM4- or RhoC-
depleted cells, as stress fibers associate with FAs to maintain
spacing and turnover [5]. Indeed, inhibition of ROCK activity
rescued the over bundled appearance of the actin stress fibers and
the loss of cellular persistence of TEM4-depleted cells.
Whereas suppression of myosin contractility by an unknown
mechanism is undoubtedly important for TEM4 function in
cellular migration, there may be additional mechanisms utilized by
TEM4 to regulate lamellar actin architecture. One possibility is
activation of other Rho effectors, such as formin proteins, by
TEM4-RhoC signaling to regulate actin stress fiber polymeriza-
tion. Loss of the formin mDia1 has been shown to impair actin
polymerization and loss of actin stress fibers was observed in cells
treated with a broad-specificity chemical inhibitor of formin
[4,72]. In addition to its role in actin polymerization, mDia1 has
also been shown to promote FA disassembly at the leading edge by
recruiting active Src kinase to FAs downstream of Rho GTPases
[73] and could therefore promote the stabilization of actin stress
fibers that we observed in cells depleted of TEM4 or RhoC.
Recent studies identified additional members of the formin family
as mediators of RhoC function [65,74]; however, the mechanism
by which these formins promote cellular migration and invasion
remains unknown.
Materials and Methods
Expression Constructs and Antibodies
Lifeact-GFP constructs were made by subcloning sequences
encoding the Lifeact [35] N-terminus to GFP in the pLL 5.0
lentiviral vector [75].Antibodies used in this study were as
following: TEM4 (4367; ProSci Inc), a-tubulin (DM1A; Sigma),
a-actinin (BM-75.2; Sigma), b-actin (AC-15; Sigma), anti-paxillin
and anti-PECAM (MEC13.3) (BD Transduction), anti-RhoA,
anti-RhoC, anti-MLC2 and anti-phospho MLC2 (Cell Signaling).
Alexa 594-conjugated phalloidin and Alexa-conjugated secondary
antibodies for the immunocytochemistry were from Invitrogen.
Nocodazole (Sigma) and Y-27632 (Calbiochem) were used at final
concentration of 10 mg/ml and 10 mM, respectively.
Endothelial Cell Culture, Lentivirus Production and
Transduction
293T cells (ATCC) were maintained in high glucose Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS). For virus production, 293T cells were
transfected using a standard calcium phosphate DNA precipitation
method with a target vector and the ViraPower lentiviral
packaging system (Invitrogen). Supernatant containing the virus
was collected 48 h post transfection and the titer was determined
by infecting fresh 293T cells.
Human umbilical vein endothelial cells (Lonza) were main-
tained in EGM-2 medium supplemented with 10% FBS
(HyClone) and endothelial cell culture additives on gelatin-coated
dishes (0.01%). For lentiviral transduction, HUVECs were
incubated with the virus (MOI,10) for 4–5 h in EGM-2 medium
in the absence of serum. HUVECs were passaged 24 h after
transduction and used for experiments 24–48 h later. All
experiments were carried out in HUVECs between passages four
and five.
ES Cell Culture and in vitro Differentiation
ES cells [22] were grown in ES medium (66% of 5637
conditioned medium [76], 17% FBS, 82.5 mM monothioglycerol
(MTG), 15% DMEM, and 0.5 mg/ml gentamicin) in dishes coated
with 0.1% gelatin. For lentiviral transduction, ES cell cultures
were incubated with undiluted viral supernatant for 4–5 h and
allowed to recover in ES cell medium overnight. 72h later, ES cells
were passaged and infected again using the same infection
protocol. Infection efficiency was estimated 48 h after the second
infection at 50–70%.
ES cell cultures were differentiated as described previously
[22,77]. Briefly, ES cells were detached (day 0) with 2.4 U/ml
dispase (Grade II stock, Boehringer-Mannheim) and replated in
bacteriologic dishes in differentiation media (DMEM supplement-
ed with 20% FBS and 150 mM MTG). EBs were transferred to a
plate with fresh differentiation media on day 2. The next day (day
3), EBs were transferred into gelatin-coated tissue culture plates in
differentiation media and fed every other day until day 8, when the
cultures were fixed and analyzed. For RNA isolation, EBs were
plated into 100 mm (earlier time points) and 60 mm plates (later
time points). For immunocytochemistry, EBs were plated in 24
well plates.
Antibody Staining and Image Analysis of ES
Differentiation Assay
Day 8 ES cell cultures were fixed with 4% PFA in PBS for
5 min and stained with anti–PECAM antibody. PECAM-stained
cultures were viewed and photographed with an inverted
microscope (IX-50; Olympus) outfitted with epifluorescence using
a 106NA 0.25 CPlan RT objective (Olympus) and a camera
(DP71; Olympus) with the DP Controller version 3.1.1.267
software (Olympus). Minor adjustments (brightness and contrast
to the whole panel) were performed using Photoshop CS3 (Adobe).
To quantify the vascular area labeled with PECAM antibody, four
wells were analyzed for each test group. For each well, six
sequential non-overlapping areas completely covered with cells
were photographed at 10x magnification, so that the total area
photographed per well was more than 60% of the well. Percent
PECAM area was calculated for each image by adjusting threshold
so the entire vessel is filled and measuring vessel area using ImageJ
‘‘Analyze Particles’’ tool. Means for each well were calculated, and
the mean of four wells for each test group was used for statistical
analysis.
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Matrigel in vitro Angiogenesis Assay
Wells of 12-well plates were coated with growth-factor reduced
Matrigel (9 mg/ml; BD BioSciences). HUVECs expressing NS
control or TEM4 shRNA were resuspended in EGM-2 and seeded
on top of solidified Matrigel matrix (66104 cells/well) in triplicate.
Tubule formation was monitored for 24 h where cells were
photographed at various time points. For each well, 4 fields/well
were photographed for each time-point and number of enclosed
spaces was counted manually and averaged.
RT-PCR Analysis
RNA was isolated using the RNeasy Mini Kit (Qiagen)
according to the manufacturer’s protocol. iScript cDNA synthesis
kit (Bio-Rad) was used for reverse transcription and cDNA was
amplified using Taq polymerase for a number of cycles were linear
amplification was observed. Primers used for the PCR- Tem4
forward primer, 59- CTGGAGGACCATGAGCAGT -39; reverse
primer, 59- GGCTGATGGCTTTTTGGAT-39; VEGFR-1/Flt-1
forward primer, 59- TGTGGTCCTATGGCGTGTT-39; reverse
primer, 59- ATCTTCATGGAGGCCTTGG-39; Gapdh forward
primer, 59- AACTTTGGCATTGTGGAAGG -39; reverse prim-
er, 59- TGTGAGGGAGATGCTCAGTG -39). In each case,
primers were designed to flank an intron and no amplification of
genomic DNA was detected.
RNA Interference
Short hairpin (shRNA) oligos were subcloned into pLL 5.0 GFP
[75] or pLL 5.0 mCherry lentivirus vectors or pLL5.0 vector
where fluorescent marker has been deleted. Target sequences were
as following: TEM4 #3 59-GCACCACTCTGAAGCGAA-39;
TEM4 #5 59-GGAAATGACATGAGGAAA-39; RhoC 59-
GGATCAGTGCCTTTGGCT -39; RhoA 59-GGAA-
GAAACTGGTGATTG-39; and mouse TEM4 59- GAACAAG-
GACTATCAGGAA -39. The control shRNA (NS; GATC-
GACTTACGACGTTAT) has no exact match in the human,
mouse or rat genomes [75].
Single Cell Tracking and Kymography Analysis
HUVECs were sparsely plated on a gelatin-coated MatTek dish
in growth medium and allowed to attach overnight. 2060.5 NA
phase time-lapse movies were recorded for 2.5 h with frames taken
every 5 min on a Nikon Biostation IM (Nikon) equipped with DS-
2MBWC camera (Nikon). In each experiment 10–12 fields were
simultaneously recorded using an automated stage. For the
analysis, every cell in each movie that met the tracking criteria
(was completely within the field of view for the entire experiment,
did not divide, and did not touch another cell for more than three
frames) was tracked using MTrackJ plug-in for ImageJ with the
point-click mode. In each case, cell centroid, defined as a half
point along the long axis of the cell, was used for tracking. Data
were exported into Microsoft Excel for analysis. The persistence of
migration was calculated as [net displacement from origin (mm)/
total length of migration paths (mm)].
For GFP-LifeAct kymography, videos were recorded for 1–2 h
with frames taken every 60 sec on an Axio Observer microscope
(Zeiss) with a plan-apochromat 6361.4 NA objective. Kymo-
graphs were assembled from equal-length videos for each
individual cell using ImageJ and lamellipodial parameters were
calculated as described [75]. Five to six lines were drawn
perpendicular to the protrusive areas in each of 4 to 6 cells and
lamellipodial parameters were calculated using custom script [75].
Parameters for each individual protrusive area within a cell were
averaged and means of 4–6 cells were used for statistical analysis.
Bimolecular Fluorescent Complementation Analysis of
Activation of RhoC
For experiments determining the specificity of BiFC reagents,
293T cells were plated in 6-well plates and transfected with VN-
RhoC, VC-RBD and tRFP (200 ng each plasmid) using calcium
phosphate precipitation method. Eighteen h after transfection the
cultures were trypsinized and replated into glass-bottom MatTek
dishes in complete growth medium. The fluorescence derived from
the BiFC and tRFP markers was visualized 24 h after transfection
using spinning disk confocal microscope (Axio Observer; Zeiss)
with a plan-apochromat 6361.4 NA objective. Images were
captured by sequential scanning with the 488 nM argon and the
561 nM HeNe1 laser and the BP 525/50 (for BiFC), BP 598 (for
tRFP) emission filters. To remove bias, tRFP-positive cells were
identified without checking for presence of the BiFC signal and
fluorescent intensities produced by BiFC and the tRFP internal
reference were recorded for each cell. To process images, cell
boundary was identified using tRFP channel and total cell
fluorescence intensity was measured in ImageJ and background
subtracted. Finally, the ratio of BiFC to tRFP fluorescence
intensity was obtained and plotted.
To analyze dynamics of activation of RhoC in HUVEC, cells
were first infected with lentivirus encoding Lifeact-tRFP and
TEM4 shRNA #3 or NS control. In this instance, mCherry
fluorescent marker was deleted from TEM4 shRNA pLL 5.0
vector by restriction digestion. Twenty-four h after the first
infection, cells were infected with lentivirus encoding VN and VC
fusions. Cells were subsequently split into glass-bottom MatTek
dishes and visualized 72 h after the first infection using a Zeiss
Observer and 6361.4 NA objective in microscopy medium
(DMEM/F12 with endothelial growth medium bullet kit (Lonza)
supplemented with 10% FBS (Characterized FBS; HyClone)).
Time-lapse images were collected every min using the following
exposure times: 550 ms for tRFP and 500 ms for BiFC-RhoC.
Image brightness and contrast were adjusted in ImageJ software.
To calculate fluorescence intensity of RhoC-BiFC, a 10 mm-wide
rectangle was drawn at the protrusive edge or inside the cell
(forward of the nucleus) and intensity in each frame of the time
lapse was measured using plot Z-axis profile tool in ImageJ. These
measurements were used to calculated edge/cell body ratio
fluorescence.
Immunocytochemistry and Microscopy
HUVECs were fixed with 4% paraformaldehyde in cytoskeletal
buffer (CS; 5 mM PIPES, pH 6, 137 mM NaCl, 5 mM KCl,
1.1 mM Na2HPO4, 0.4 mM KH2PO4, 0.4 mM MgCl2, 0.4 mM
NaHCO3, 2 mM EGTA, 50 mM glucose) for 15 min. In
experiments described in Figs. 5 and 8, cytosolic a-actinin was
eluted by a simultaneous fixation-prepermeabilization protocol
(5 min in 0.5% Triton X-100, 3% PFA in CS buffer, 15 min in
3% PFA in CS). Cells were permeabilized with 0.2% Triton X-
100 for 5 min, blocked with 5% BSA and stained with antibodies.
FluorSave reagent (EMD Chemicals) was used as the mounting
media. Cells were examined with an inverted laser scanning
confocal microscope LSM 510 (Carl Zeiss, Inc) using an oil
immersion plan-apochromat 6361.4 NA objective. Images were
captured by sequential scanning with the 488 nM argon/633 nM
HeNe2 lasers and the 543 nM HeNe1 laser (488 nM and 543 nM
for 2-color staining), and the BP 505–530 (for Alexa 488), BP 585–
615 (for Alexa 594 and mCherry), or LP 650 (for Alexa 647)
emission filters and recorded by the LSM software (Zeiss). For
scoring, images were captured using plan-apochromat 4061.2 NA
objective and number of cells with tight bundles of actin
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crosslinked by a-actinin was counted manually. Image brightness
and contrast were adjusted using Adobe Photoshop CS3.
Focal Adhesion Analysis
Cells were plated on gelatin-coated 15-mm glass slides and
allowed to attach overnight. Cells were fixed using a simultaneous
permeabilization-fixation protocol and stained with rabbit anti-
paxillin antibodies and phalloidin. Only cells with a single nucleus
were used for the analysis to avoid variations in a total number of
FAs due to cell size. The number of FAs per cell was quantitated
from thresholded images using ImageJ. Raw time-lapse data were
used for measurement of FA dynamics. For presentation purposes,
brightness and contrast were adjusted using Adobe Photoshop
CS3.
Statistical Analysis
Prizm software was used for statistical analysis. In each case, p-
values were calculated using a two-tailed unpaired t-test assuming
unequal variance. Significance for all tests was assumed at p,0.05
(alpha 0.05).
Supporting Information
Figure S1 Lentiviral vector-based shRNA plasmid de-
sign used in the study. (A) Diagram of the modified lentiviral
vector combining shRNA expression from the Pol III U6
promoter with GFP or mCherry fluorescent proteins expression
from the MSCV 59 LTR promoter to identify infected cells for the
analysis. (B) HUVECs were infected with TEM4 shRNA #3 co-
expressing mCherry. Twenty-four h after infection cells were fixed
and stained with nuclear marker. Infection efficiency was
determined by counting cells not expressing mCherry (uninfected
cells; marked with an arrowhead) and is 96% for the field shown.
At the chosen MOI (,10) lentiviral infection efficiency neared
100% in every experiment.
(TIF)
Figure S2 Characterization of BiFC-RhoC probe speci-
ficity. (A) Schematic diagram of lentiviral vector-based shRNA
plasmids used in the study. ORFs are drawn not to scale. (B-D)
The wild-type or mutated RhoC and RBD were co-transfected
into 293T with an internal control (tRFP). (B) Western blot
confirming the expression of BiFC constructs in 293T cells. GFP
antibody was used to detect VN fusions. Antibody against ROCKI
was used to detect VC fusions. (C-D) Fluorescent intensities
produced by BiFC and the internal reference were measured in
individual cells (30–54 cells for each group) and the ratio is
displayed as a distribution between individual cells (D) or a mean
(C).
(TIF)
Figure S3 BiFC-RhoC in endothelial cells. (A) Individual
frames from time-lapse movies show the fluorescent levels of
RhoC-BiFC, GFP-RhoC or GFP alone in HUVECs. Arrows mark
protruding areas of the cell. (B) Western blot analysis of BiFC
constructs in HUVECs. RhoC antibodies were used to compare
expression levels of VN-RhoC fusions to the endogenous RhoC.
Antibody against ROCKI was used to detect the VC fusions. (C)
BiFC requires wild type RhoC and ROCK as mutation of either
RhoC or ROCK abolished BiFC-derived signal. (D–E) Activation
of RhoC in NS control (D) or TEM4-depleted cells (E). BiFC-
RhoC fluorescent signal was recorded in four cells in each
experimental group. Scale bar, 10 mm.
(TIF)
Figure S4 TEM4 and RhoC antagonize activation of
RhoA. (A) Knockdown of TEM4 or RhoC promotes activation of
RhoA. Cells depleted of TEM4 or RhoC or NS control were left
untreated (GM), treated with nocodazole (Noc) or treated with
nocodazole with subsequent nocodazole washout. Active RhoA
was pulled down in GTPase pull-down assay and levels of active
and total RhoA were determined by western blot analysis. (B)
Western blot confirming knockdown of RhoA and RhoC
expression levels by lentivirus-based RNAi constructs in cells used
for single cell tracking. NS; non-specific shRNA. (C) Persistence of
two-dimensional cellular migration of HUVECs expressing NS,
RhoC or RhoA shRNAs or treated with Y-27632. (D) Wind-Rose
plots depicting migratory tracks of six individual migrating cells in
each experimental group. Values on x and y scales are arbitrary.
(TIF)
Figure S5 Localization of endogenous TEM4 to actin
filaments and microtubules in protrusive areas of the
cell. (A) HUVECs were stained with antibodies against TEM4
and a-tubulin and Alexa-594 phalloidin. The close-up of cell
periphery (B) or cell body (C) is shown. Specificity of TEM4
staining was confirmed by preincubating the TEM4 antibody with
TEM4 immunizing peptide (E) or control peptide (D) of similar
length. Scale bar 10 mm.
(TIF)
Movie S1 Migration of NS control HUVECs. HUVECs
were infected with lentivirus encoding NS control shRNA and
plated on gelatin-coated plates. Cellular migration was recorded
using a bright field microscope (Nikon Biostation IM) for 2.5 h
with an acquisition rate of 5 min/frame. Movies played at a speed
of 5 frames-per-second. Scale, 10 mm.
(MOV)
Movie S2 Migration of HUVECs with decreased expres-
sion of TEM4. HUVECs were infected with lentivirus encoding
TEM4 shRNA #3 and plated on gelatin-coated plates. Cellular
migration was recorded using a bright field microscope (Nikon
Biostation IM) for 2.5 h with an acquisition rate of 5 min/frame.
Movies played at a speed of 5 frames-per-second. Scale, 10 mm.
(MOV)
Movie S3 Migration of HUVECs with decreased expres-
sion of RhoC. HUVECs were infected with lentivirus encoding
RhoC shRNA and plated on gelatin-coated plates. Cellular
migration was recorded using a bright field microscope (Nikon
Biostation IM) for 2.5 h with an acquisition rate of 5 min/frame.
Movies played at a speed of 5 frames-per-second. Scale, 10 mm.
(MOV)
Movie S4 RhoC activation in NS control HUVECs.
HUVECs were infected with lentiviruses encoding Lifeact-tRFP
and NS control. Twenty-four h after the first infection, cells were
infected with RhoC-BiFC biosensor components. Time-lapse
images of RhoC-BiFC (left panel) and Lifeact-tRFP (right panel)
were recorded using a spinning disk confocal microscope (Zeiss
Observer; Carl Zeiss, Inc.). Frames were recorded for 34 min with
an acquisition rate of 1 frame/min and played at a speed of 5
frames-per-second. Scale bar, 10 mm.
(MOV)
Movie S5 RhoC activation in TEM4-depleted HUVECs.
HUVECs were infected with lentiviruses encoding Lifeact-tRFP
and TEM4 shRNA #3. Twenty-four h after the first infection,
cells were infected with RhoC-BiFC biosensor components. Time-
lapse images of RhoC-BiFC (left panel) and Lifeact-tRFP (right
panel) were recorded using a spinning disk confocal microscope
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(Zeiss Observer; Carl Zeiss, Inc.). Frames were recorded for a total
period of 41 min, using an acquisition rate of 1 frame/min and
played at a speed of 5 frames-per-second. Scale bar, 10 mm.
(MOV)
Movie S6 Actin cytoskeleton dynamics in control HU-
VECs. HUVECs were infected with lentiviruses encoding NS
control shRNA and Lifeact-tRFP. Time-lapse images of Lifeact-
tRFP were recorded using a spinning disk confocal microscope
(Zeiss Observer; Carl Zeiss, Inc.). Frames were recorded for
68 min with an acquisition rate of 1 frame/min and played at a
speed of 5 frames-per-second. Scale bar, 10 mm.
(MOV)
Movie S7 Actin cytoskeleton dynamics in RhoC-deplet-
ed HUVECs. HUVECs were infected with lentiviruses encoding
RhoC shRNA and Lifeact-tRFP. Time-lapse images of Lifeact-
tRFP were recorded using a spinning disk confocal microscope
(Zeiss Observer; Carl Zeiss, Inc.). Frames were recorded for
120 min with an acquisition rate of 1 frame/min and played at a
speed of 5 frames-per-second. Scale bar, 10 mm.
(MOV)
Movie S8 Treatment with Y-27632 restores persistence
of HUVECs depleted of TEM4. HUVECs were infected with
lentivirus encoding TEM4 sh#3 shRNA and plated on gelatin-
coated plates. Cells were pretreated with 10 mM Y-27632 for
30 min and cellular migration was recorded using a bright field
microscope (Nikon Biostation IM) for 3 h with an acquisition rate
of 5 min/frame. Movies played at a speed of 5 frames-per-second.
Scale, 10 mm.
(MOV)
Movie S9 Migration of control HUVECs treated with Y-
27632. Cells were pretreated with 10 mM Y-27632 for 30 min
and cellular migration was recorded using a bright field
microscope (Nikon Biostation IM) for 3 h with an acquisition rate
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